Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Rhythm Pharmaceuticals Announces Participation at Upcoming Investor Conference
-
AVRICORE HEALTH CORPORATE UPDATE – COMPANY ACHIEVES PROFITABILITY
-
Texas Must Close Primary Elections
-
Medicenna Reports Significant Survival Benefit in Patients with Recurrent Glioblastoma Following Treatment with Bizaxofusp When Compared to a Matched External Control Arm at the 2024 ASCO Annual Meeti
-
Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024
-
Genesis Offers New Tools and Incentives to Financial Industry Software Developers
-
Denali Therapeutics Announces FDA Has Selected DNL126 (ETV:SGSH) for MPS IIIA (Sanfilippo Syndrome Type A) for START Pilot Program Intended to Accelerate Development of Rare Disease Therapies
-
BriaCell Presents Clinical Efficacy Data at ASCO 2024
-
Tonix Pharmaceuticals Presented New Data on Tonmya™ Suggesting Activity for Improvement in Fibromyalgia-Associated Depression Severity in an Oral Presentation at ASCP Annual Meeting
-
Entera Bio Reports Phase 1 Clinical Data of First-in-Class, Oral PTH(1-34) Peptide Candidate (EB612) for Patients with Hypoparathyroidism at ENDO 2024
-
PetMed Express, Inc. Announces Strategic Updates to Executive Leadership Team
-
STMicroelectronics Announces Status of Common Share Repurchase Program
-
Enphase Energy Launches IQ Battery 5P in Canada
-
KULR Announces Expiration of SEPA Facility and Compliance with NYSE Guidelines on Audit Opinion Disclosure
-
Apogee Minerals Announces Appointment of New Director
-
ASP Isotopes Inc. Receives Purchase Order from a Leading Global Industrial Gases Company for the Supply of Highly Enriched Electronic Gases
-
ORYZON Announces Journal Publication of Final Phase IIa ALICE Results with Iadademstat in The Lancet Hematology
-
Abacus Life and AIMCOR Announce New National Distribution Agreement
-
Replimune Presents Positive Data from RP1 and RP2 Clinical Programs at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
-
Gabelli Funds to Host 16th Annual Media & Entertainment Symposium Thursday, June 6, 2024
-
Core Molding Technologies to Present and Host 1x1 Meetings at the 14th Annual East Coast IDEAS Conference on June 13, 2024
-
Arcutis to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
-
Mineralys Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
-
ConnectWise Research finds 78% of SMBs Concerned a Cyber Attack Could Put Their Organizations Out of Business
-
Introducing the TimeProvider® XT Extension System for Migrating to a Modern Synchronization and Timing Systems Architecture
-
DZS Completes NetComm Acquisition
-
ASP Isotopes Inc. Receives Purchase Order from a Leading Global Industrial Gases Company for the Supply of Highly Enriched Electronic Gases
-
European Cup Inu: Transforming the Euro 2024 Experience with Innovative Crypto Betting
-
Syntec Optics (Nasdaq: OPTX) to Participate in the “Charting the Course: Navigating the Intersection of TMT and Business in the AI Era” Conference
-
Cyclacel Pharmaceuticals Reports New Clinical Data at 2024 ASCO Annual Meeting Highlighting Oral Fadraciclib’s Potential as a Precision Medicine for Cancer
-
VCI Global Gives Full Year Guidance After Seeing Revenues Increase Over 145% in 2023
-
LiveOne to Host Special Investor Webcast to Provide Update on Strategic Partnerships, B2B Pipeline and Addressable Market for all Subsidiaries
-
The Metals Company Welcomes Prominent Sustainability Strategist Brendan May to its Board of Directors
-
FangDD Announces Termination Plan for Its ADR Facility, and the Plan to Hold an Extraordinary General Meeting of Shareholders
-
Scorpius Holdings and Beyond Imagination Announce Trailblazing Partnership to Utilize Autonomous AI-Powered Humanoid Robots for American Biomanufacturing
-
Corcept Therapeutics Announces Presentations of Results of Pivotal Phase 3 GRACE Trial Evaluating Relacorilant in Patients with Hypercortisolism (Cushing’s Syndrome)
-
Aquestive Therapeutics Announces Executive Appointments and Builds Commercial Capabilities
-
Getty Realty Corp. Publishes 2024 Corporate Responsibility Report
-
23andMe Therapeutics Announces Positive Preliminary Phase 2 Safety and Efficacy Results for 23ME-00610, targeting CD200R1, at the 2024 ASCO Annual Meeting
-
aTyr Pharma Announces Nasdaq Stock Ticker Symbol Change from “LIFE” to “ATYR”
-
Live Oak Bank Announces First Embedded Banking Partnership with Anatomy Financial, Inc.
-
Indaptus Therapeutics Announces New Positive Data from Ongoing Phase 1 Trial of Decoy20
-
RUMI Scientific announces Receipt of Two-Year Phase II SBIR Award totaling $1.9 Million to Accelerate Discovery and Development of Novel Therapeutic Candidates for the Treatment of Autism
-
Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences in June 2024
-
VoIP-Pal Files New Patent Infringement Against Lawsuits Against Verizon, and T-Mobile, Asserting its RBR Patents in U.S. District Court for the Western District of Texas, Waco Division
-
AcreTrader Management Assists in Exit of Wabash County, Indiana Row Crop Farm Disposition
-
Gabelli Funds to Host 16th Annual Media & Entertainment Symposium Thursday, June 6, 2024
-
CSW Industrials Names Darron Ash to Board of Directors, Supporting Commitment to Disciplined Capital Allocation, Corporate Responsibility and Board Succession Planning
-
Enlivex Receives Regulatory Authorization for the Initiation of a Placebo-Controlled Phase I/II Trial Evaluating Allocetra in Up To 46 Patients with Thumb Osteoarthritis
-
USI Insurance Services Launches PATH, a Proprietary Technology-Enabled Risk Control Platform
